Chemours (CC) Misses Q3 EPS by 7c

Chemours (NYSE: CC) reported Q3 EPS of $0.63, $0.07 worse than the analyst estimate of $0.70. Revenue for the quarter came in at $1.5 billion versus the consensus estimate of $1.52 billion.

For earnings history and earnings-related data on Chemours (CC) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
• Workhorse Group (WKHS) Misses Q2 EPS by 77c